Rankings / Mood, Anxiety & Stress
GABA (gamma-aminobutyric acid)
Mood, Anxiety & Stress · Inhibitory neurotransmitter / supplement
Tier C+
Bottom line
Read Off Label grades GABA (gamma-aminobutyric acid) as C+ (5.3/10) based on weak evidence, low benefit magnitude, and a low-risk safety profile.
The BBB-penetration question is the central debate — biochemistry says no, EEG and HRV studies show acute effects within ~30 min, which the field explains via enteric/vagal signaling.
Studied, labeled, or reported-use context: 100-750 mg/day; PharmaGABA (natural fermentation) often cited as preferable to synthetic, evidence thin — OTC; not individualized guidance.
What the evidence says
The BBB-penetration question is the central debate — biochemistry says no, EEG and HRV studies show acute effects within ~30 min, which the field explains via enteric/vagal signaling. Either way, the reported effect size is small, evidence does not establish equivalence to clinical anxiolytics, and studies report a comparatively low adverse-event burden. GABA is pharmacologically distinct from phenibut and gabapentin.
Mechanism
Endogenous inhibitory neurotransmitter; oral supplement penetrates blood-brain barrier poorly; proposed peripheral mechanism via enteric GABA receptors and vagal afferents; fermented (PharmaGABA from Lactobacillus hilgardii) may behave differently from synthetic
Studied, labeled, or reported dose & route
100-750 mg/day; PharmaGABA (natural fermentation) often cited as preferable to synthetic, evidence thin
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about GABA (gamma-aminobutyric acid)'s effects?
- Read Off Label rates the evidence for GABA (gamma-aminobutyric acid) as Weak and the benefit magnitude as low, producing an overall grade of C+ (5.3/10). The BBB-penetration question is the central debate — biochemistry says no, EEG and HRV studies show acute effects within ~30 min, which the field explains via enteric/vagal signaling.
- What safety findings are reported for GABA (gamma-aminobutyric acid)?
- GABA (gamma-aminobutyric acid) has a low risk profile in the database. Low (rare transient flushing/dyspnea; no dependence signal at typical doses) Legal status: OTC.
- What doses or routes are reported for GABA (gamma-aminobutyric acid)?
- 100-750 mg/day; PharmaGABA (natural fermentation) often cited as preferable to synthetic, evidence thin This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does GABA (gamma-aminobutyric acid) work?
- Endogenous inhibitory neurotransmitter; oral supplement penetrates blood-brain barrier poorly; proposed peripheral mechanism via enteric GABA receptors and vagal afferents; fermented (PharmaGABA from Lactobacillus hilgardii) may behave differently from synthetic
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.